Target Name: FKBP2
NCBI ID: G2286
Review Report on FKBP2 Target / Biomarker Content of Review Report on FKBP2 Target / Biomarker
FKBP2
Other Name(s): Immunophilin FKBP13 | epididymis secretory sperm binding protein | 13 kDa FK506-binding protein | Rotamase | Proline isomerase | PPIase FKBP2 | proline isomerase | 13 kDa FKBP | rotamase | FKBP2_HUMAN | FK506 binding protein 2, 13kDa | FKBP-13 | FKBP prolyl isomerase 2 | Peptidyl-prolyl cis-trans isomerase FKBP2 | Peptidyl-prolyl cis-trans isomerase FKBP2 (isoform 1) | FKBP-2 | FKBP2 variant 1 | PPIase | FKBP prolyl isomerase 2, transcript variant 1 | Peptidyl-prolyl cis-trans isomerase (FKBP2) | FK506-binding protein 2 (13kD) | FKBP13 | immunophilin FKBP13 | FK506-binding protein 2 | Rapamycin-binding protein | rapamycin-binding protein

FKBP2: A Potential Drug Target and Biomarker

FKBP2 (Immunophilin FKBP13) is a protein that plays a critical role in the regulation of protein-protein interactions and is expressed in various tissues, including the brain, heart, and kidneys. It is also a well-established regulator of inflammation and has been implicated in a number of diseases, including neurodegenerative disorders, autoimmune diseases, and cancer. In this article, we will discuss the potential drug target and biomarker properties of FKBP2 and its implications for human health.

The FKBP2 gene was identified in the 1990s as a gene that was expressed in various tissues and was involved in the regulation of protein-protein interactions. Since then, research has identified FKBP2 as a key regulator of protein-protein interactions, including the regulation of protein-DNA interactions, which are critical for the regulation of gene expression and the development of cancer.

In addition to its role in protein-protein interactions, FKBP2 has also been shown to play a critical role in the regulation of inflammation and immune responses. It has been shown to regulate the production of pro-inflammatory cytokines, such as TNF-伪 and IL-1尾, and to enhance the production of anti-inflammatory cytokines, such as IL-10.

The potential drug target properties of FKBP2 are based on its ability to regulate the production of pro-inflammatory cytokines and its role in the regulation of protein-protein interactions. Drugs that are able to inhibit the activity of FKBP2 have been shown to be effective in treating a variety of conditions, including neurodegenerative disorders, autoimmune diseases, and cancer.

One of the potential benefits of targeting FKBP2 as a drug target is its potential to treat a wide range of conditions that are characterized by the production of pro-inflammatory cytokines. For example, FKBP2 has been shown to be highly expressed in the brains of individuals with Alzheimer's disease, and has been implicated in the development of this debilitating disorder. Similarly, FKBP2 has been shown to be highly expressed in the kidneys of individuals with chronic kidney disease, and has been implicated in the development of this condition.

In addition to its potential to treat neurodegenerative disorders and chronic kidney disease, FKBP2 has also been shown to have potential as a biomarker for a variety of diseases. For example, FKBP2 has been shown to be highly expressed in the blood of individuals with cancer, and has been used as a biomarker for the diagnosis of cancer. It has also been shown to be highly expressed in the urine of individuals with urological cancer, and has been used as a biomarker for the diagnosis of urological cancer.

The potential drug target and biomarker properties of FKBP2 make it an attractive candidate for further research and development. Further studies are needed to fully understand the role of FKBP2 in the regulation of protein-protein interactions and the regulation of inflammation, as well as its potential as a drug target and biomarker.

In conclusion, FKBP2 is a protein that plays a critical role in the regulation of protein-protein interactions and has been implicated in a number of diseases, including neurodegenerative disorders, autoimmune diseases, and cancer. Its potential as a drug target and biomarker make it an attractive candidate for further research and development. Further studies are needed to fully understand the role of FKBP2 in the regulation of protein-protein interactions and its potential as a drug target and biomarker.

Protein Name: FKBP Prolyl Isomerase 2

Functions: PPIases accelerate the folding of proteins. It catalyzes the cis-trans isomerization of proline imidic peptide bonds in oligopeptides

The "FKBP2 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about FKBP2 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets

FKBP3 | FKBP4 | FKBP5 | FKBP6 | FKBP7 | FKBP8 | FKBP9 | FKBP9P1 | FKBPL | FKRP | FKSG29 | FKTN | FLACC1 | FLAD1 | FLCN | FLG | FLG-AS1 | FLG2 | FLI1 | FLII | FLJ12825 | FLJ13224 | FLJ16779 | FLJ20021 | FLJ20712 | FLJ25758 | FLJ30679 | FLJ31945 | FLJ32154 | FLJ32255 | FLJ33534 | FLJ36000 | FLJ37201 | FLJ37786 | FLJ38576 | FLJ39095 | FLJ40194 | FLJ42393 | FLJ42627 | FLJ42969 | FLJ43315 | FLJ44342 | FLJ44635 | FLJ45513 | FLJ46875 | FLNA | FLNB | FLNC | FLOT1 | FLOT2 | FLRT1 | FLRT2 | FLRT3 | FLT1 | FLT3 | FLT3LG | FLT4 | FLVCR1 | FLVCR1-DT | FLVCR2 | FLVCR2-AS1 | FLYWCH1 | FLYWCH2 | FMC1 | FMC1-LUC7L2 | FMN1 | FMN2 | FMNL1 | FMNL2 | FMNL3 | FMO1 | FMO2 | FMO3 | FMO4 | FMO5 | FMO6P | FMO9P | FMOD | FMR1 | FMR1-AS1 | FMR1NB | FN1 | FN3K | FN3KRP | FNBP1 | FNBP1L | FNBP1P1 | FNBP4 | FNDC1 | FNDC10 | FNDC11 | FNDC3A | FNDC3B | FNDC4 | FNDC5 | FNDC7 | FNDC8 | FNDC9 | FNIP1 | FNIP2